- 英文名称
- Orbifloxacin
- 分子式
- C19H20F3N3O3
- 分子量
- 395.38
- 中文别名
- 1-环丙基-5,6,8-三氟-7-(顺式-3,5-二甲基哌嗪)-1,4-二氢-4-氧代喹啉-3-羧酸; 1-环丙基-5,6,8-三氟-7-(CIS-3,5-二甲基哌嗪)-1,4-二氢-4-氧-喹啉-3-羧酸; ORBAX; ORBIFLOXACIN; 1-CYCLOPROPYL-7-(3,5-DIMETHYL-PIPERAZIN-1-YL)-5,6,8-TRIFLUORO-4-OXO-1,4-DIHYDRO-QUINOLINE-3-CARBOXYLIC ACID; 1-CYCLOPROPYL-5,6,8-TRIFLUORO-1,4-DIHYDRO-7-(CIS-3,5-DIMETHYL-1-PIPERAZINYL)-4-OXO-QUINOLINE-3-CARBOXYLIC ACID; Obixacin; 1-Cyclopropyl-5,6,8-trifluoro-1,4-dihydro-7-(3β,5β-dimethyl-1-piperazinyl)-4-oxoquinoline-3-carboxylic acid; 1-cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylic acid; 1-cyclopropyl-7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; 1-Cyclopropyl-7-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-5,6,8-trifluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid; 1-Cyclopropyl-7-(cis-3,5-dimethylpiperazin-1-yl)-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- 用途
- 喹诺酮类动物专用抗菌药物，用于治疗猪的肺炎与腹泻病，犬、猫的敏感菌感染，对革兰氏阴性菌、阳性菌及支原体等有良好抗菌活性，生物利用度89%～100%，高于恩诺沙星和单诺沙星，无体内积蓄和残留。
